Inclusion of adolescents in adult clinical trials will increase young patients access to safe and efficacious treatments in a timely manner.
TORONTO (PRWEB) October 30, 2020
The PRA Health Sciences Center for Pediatric Clinical Development’s second annual acknowledgement of World Children’s Day will be celebrated virtually on November 16, 2020. World Children’s Day is celebrated to commemorate the Convention on the Rights of the Child, which is the most widely ratified human rights treaty in history and has helped transform children’s lives around the world. It sets defined parameters to ensure humanity recognizes the equality necessary for children to develop to their full potential.
PRA Health Sciences is promoting international togetherness and awareness of children worldwide, as well as improving children’s welfare.
In this webinar, the speakers will discuss ongoing health disparities and social determinants, diversity (and the lack thereof) in clinical trial participation, inclusion of adolescents in adult clinical trials, clinical trial education of the public and survey results of the “Pediatric Perceptions and Insights” study conducted by the Center for Information and Study on Clinical Research Participation (CISCRP).
Being a member of a racial or ethnic minority, compounded with the lack of awareness and health care access, continue to be a barrier to bringing appropriate clinical trial participation and safe and effective treatments for chronic and debilitating diseases to the pediatric population. Panelists will discuss experienced barriers and how to defy prejudice and encourage diversity.
Inclusion of adolescents in adult clinical trials will increase young patients access to safe and efficacious treatments in a timely manner. Including the ages of 12 to under 18 years in adult clinical trials will eliminate the extended time while waiting for the adult trial results and may help for trial design to support pediatric indications when warranted based on preliminary results. Not including adolescents leads to off label prescribing lacking scientific evidence of safe and efficacious dosing.
The live webinar will include a panel discussion with three young adults moderated by Dr. Gaspar. Two of the young adult panelists have participated in adult clinical trials as adolescents and one panelist with a rare disease sharing barriers of participation and advocacy to create a collaborative platform for patients and researchers.
Join Dr. Hemant Malhotra, Medical Oncologist, Department of Medical Oncology, Mahatma Gandhi College Hospital; Dr. Nathalie Gaspar, Paediatric Oncologist, Gustave Roussy Cancer Campus; Annick deBruin, Senior Director of Research Services, CISCRP, in the live webinar on Monday, November 16, 2020 at 10am EST (3pm GMT/UK).
The webinar will also feature youth panelists Benjamin James, an MSc (Merit) Science communication graduate from the University of Sheffield who has Duchenne Muscular Dystrophy (DMD) and is a trustee for Pathfinders Neuromuscular Alliance; Rime Allouche, who is a member of KIDS France and advocates to ensure the voice of children and young adults is represented in clinical trials; and Max Williamson, a young cancer patient and patient advocate on the Teenage and Young Adult Cancer research group of the UK’s National Cancer Research Institute.
For more information, or to register for this event, visit PRA’s World Children’s Day Event: Defying Health Care Disparities and Clinical Trial Barriers in Pediatric Populations.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.